Michael S. Kinch

Michael Kinch Photo by Joe Angeles/WUSTL Photos

  Dr. Kinch has been appointed the inaugural Chief Innovation Officer (CINO) at Stony Brook University, beginning August 1, 2024. In the course of his career, he has founded and led drug discovery enterprises in both industry and academia, including founding oncology at MedImmune, Inc. and founding the Center for Molecular Discovery at Yale University and the Center for Drug Discovery at Washington University in St Loui

In 2010, Dr. Kinch began a program to catalog all medicines ever approved or subjected to clinical testing in people. This project reflects his  scientific background, which includes the development of medicines for cancer, immunological and infectious diseases. Prior to Long Island University, Michael was an Associate Vice Chancellor at Washington University in St Louis. He also led drug discovery at Yale University as Managing Director of the Yale Center for Molecular Discovery. Dr. Kinch had served as Vice President of Research & Development and Chief Scientific Officer at Functional Genetics, Inc. in Gaithersburg, MD, where his research included investigation of Ebola, Dengue fever, pandemic influenza and other emerging infectious diseases. Preceding that, Dr. Kinch led the Departments of Cancer Biology and In Vivo Biology at MedImmune, Inc.  Prior to MedImmune, Dr. Kinch served as a tenured associate professor at Purdue University. Dr. Kinch was a postdoctoral fellow at the University of North Carolina at Chapel Hill, obtained a Ph.D. in Immunology from Duke University and a B.S. in Molecular Genetics from The Ohio State University. He has published more than 100 manuscripts, and been granted 15 US patents. His first book, A Prescription for Change (UNC Press, 2016), outlines a history of the biotechnology and pharmaceutical industries. Michael’s second book, Between Hope and Fear (Pegasus Books, 2018) details the history of vaccines and public reaction to these vital tools. The End of the Beginning (Pegasus Books, 2019) provides a history of new cancer therapies with the potential promise to eradicate this disease. The Price of Health (Simon & Schuster, 2021), investigates the rationale contributing to the rise in drug prices and what might be done about this key problem. The Pantheon and the Mortuary is a text intended to instill the fundamentals of biomedical entrepreneurship for young and old alike, using real-world applications. 


A Prescription for Change

Between Hope and Fear

End of the Beginning

The Price of Health

The Pantheon and the Mortuary


Speaker requests: Leigh Bureau

Consulting: Jee-Yeon Lehmann | Analysis Group